PAP
GDRX icon

Persistent Asset Partners’s GoodRx Holdings GDRX Stock Holding History

Persistent Asset Partners’s Portfolio GDRX Stock Details GDRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-101,755
Closed -$449K – 204
2025
Q1 		$449K Buy
+101,755
New +$478K 0.38% 61

Other funds holding GDRX

FPM
Francisco Partners Management San Francisco, California $292M AUM 34.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
LCM
Lakewood Capital Management New York $1.58B AUM 0.92% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
SLG
Silver Lake Group Menlo Park, California $3.68B AUM 7.22% 1-Year Est. Return
PTC
Petrus Trust Company Dallas, Texas $915M AUM 2.95% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Connor, Clark & Lunn Investment Management (CC&L)
Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $43.4B AUM 51.29% 1-Year Est. Return

Persistent Asset Partners's GDRX Position: Q2 2025 in Review

Persistent Asset Partners sold out of GoodRx Holdings (GDRX) in Q2 2025, closing a stake of 101,755 shares — an estimated $449K sold.

Persistent Asset Partners first reported a position in GDRX in Q1 2025 and held it in 1 quarter. The position peaked at $449K in Q1 2025. 182 funds tracked by Wall St. Rank hold GDRX as of Q2 2025.

  • Persistent Asset Partners reported no remaining GoodRx Holdings position as of Q2 2025 after selling out during the quarter.
  • Persistent Asset Partners sold 101,755 GoodRx Holdings shares in Q2 2025, an estimated $449K.
  • Persistent Asset Partners first reported a position in GoodRx Holdings in Q1 2025 and held it in 1 quarter.
  • Persistent Asset Partners's GoodRx Holdings position peaked at $449K in Q1 2025.
  • 182 funds tracked by Wall St. Rank held GoodRx Holdings as of Q2 2025.

Based on Persistent Asset Partners's 13F filing for Q2 2025, filed 11 Aug 2025.